Back to search
Awaiting Organ Transplant
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Awaiting Organ Transplant trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Awaiting Organ Transplant trials you may qualify forThis phase 1B trial tests the safety, side effects and best dose of rh-Hsc70- BZLF1 peptide complex (OSU-2131) with Stimulon (Trademark) QS-21 and evaluates how…
The treatment and care of chronic kidney failure is a long-term process, and patients are significantly affected by this condition. The fact that patients spend…
HIV-infected (HIV+) individuals who agree to accept and receive a solid organ transplant from an HIV+ deceased donor will be followed to determine the safety an…
The primary objective of this study is to evaluate the safety of solid organ transplantation using HIV-positive deceased donors (liver, kidney) and HIV-positive…
HB-101 is a bivalent recombinant vaccine against human CMV infection. This is a randomized, placebo-controlled, phase 2 study to assess the safety, reactogenici…
This is an open-label, pilot safety and efficacy trial for adults who are active on the heart, lung, or kidney transplantation lists and are eligible to receive…
The objective of this clinical trial is to compare the response rate obtained with two different vaccination schemes against HBV in cirrhotic patients. These pa…
Cytomegalovirus (CMV) is a common infection with 60-90% of all adults worldwide having evidence of having the infection at sometime in their life. Patients who…